Uracil

Uracil Impurities

Uracil impurities include synthetic intermediates, process-related compounds, and degradation products that may arise during synthesis, purification, or storage. As a naturally occurring pyrimidine base found in RNA and used in pharmaceutical synthesis (e.g., antimetabolites like fluorouracil), impurity profiling is essential to ensure product safety, therapeutic efficacy, and regulatory compliance. All impurity compounds are structurally characterized and qualified under ICH guidelines for toxicological evaluation and analytical validation.

Uracil EP Impurities

We offer pharmacopeial and non-pharmacopeial Uracil impurity compounds that conform to European Pharmacopoeia (EP) specifications. These standards support method development, impurity profiling, and stability studies. EP traceable compounds are available upon request and are supplied with validated analytical data including HPLC purity, NMR, and MS characterization.

Uracil Related Compounds

Our catalog includes structurally related compounds and synthetic intermediates associated with Uracil. These include arabinosyl conjugates, and functionalized pyrimidine analogs. Related substances are used in forced degradation studies, impurity identification, and toxicological qualification. All entries are supported by comprehensive analytical documentation and meet international regulatory expectations.

Uracil Impurity Reference Standards

Uracil impurity reference standards are supplied with validated analytical data including NMR, MS, and HPLC purity. These compounds are used in pharmaceutical R&D, method validation, and GMP-compliant quality control. EP/USP traceable entries are available upon request. All products are re-tested at regular intervals to ensure consistency and reliability.